Skip to main content
Log in

Journal updates

  • Featured article: Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine

    Pituitary neuroendocrine tumors (PitNETs) are the second most common primary central nervous system tumors in adults. Among them, non-functional PitNET (NF-PitNET), a PitNET with hormone synthesis but without hormone hypersecretion symptoms, is accounted for 15 ~ 54%. A series of molecules are involved in NF-PitNET pathogenesis that alter in multiple levels of genome, transcriptome, proteome, and metabolome. These molecules mutually interact to form dynamically associated molecular-network systems. 

    In this review article, Wen and colleagues explore the current knowledge of single omics and integrative omics of NF-PitNETs and highlight key signaling pathways and signaling pathway network alterations identified from multi-omics data. Researcher emphasized the altered signaling pathways and their key molecules related to NF-PitNET invasiveness and aggressiveness that are challenging clinical problems.

  • Featured article: Caution, “normal” BMI —EPMA Position Paper 2021

    An increasing interest in a healthy lifestyle raises questions about optimal body weight. It should be clearly discriminated between the standardised “normal” body weight and individually optimal weight, and the basic principle of personalised medicine “one size does not fit all” has to be applied. 


    Development of innovative screening programmes is essential to promote population health by application of individualised patient profiling, multi-parametric analysis leading to cost-effective targeted prevention.


    In a long-term way, a significantly improved healthcare economy is one of the clear benefits of the proposed paradigm shift from reactive medicine to 3PM; a tight collaboration between all stakeholders including scientific community, healthcare providers, patient organisations, policy-makers and educators is essential for the smooth implementation of the 3PM concepts.

  • 2020 Journal Metrics

    SCImago Journal Rank (SJR) measures weighted citations received by the journal. In 2020, the SJR for EPMA Journal is 1.177 (this opens in a new tab), placing it in the 1st quartile of the 'Health Policy' category, with particularly high level of international collaboration amongst researchers.


    Scopus CiteSore measures average citations received per document published. The 2020 CiteSore for EPMA Journal is 9.000 (this opens in a new tab). This ranks the journal as 5th in the 'Health Policy' category, within the 98th percentile.


    Source-Normalized Impact per Paper (SNIP) measures actual citations received relative to citations expected for the journal’s subject field. The 2020 SNIP for EPMA Journal is 1.422 (this opens in a new tab).

  • Featured article: Making a complex dental care tailored to the person

    Oral cavity health is pivotal for prediction and prevention of associated pathologies. Inadequately provided oral health services in populations are caused by multi-factorial deficits. 


    In this study, researchers investigated a variety of factors to determine key parameters for patient stratification considering person-tailored approach in a complex dental care in the population. 

  • Featured article: Challenging management of severe chronic disorders in acute pandemic situation

    Chronic liver disease management is a comprehensive approach requiring multi-professional expertise and well-orchestrated healthcare measures thoroughly organized by responsible medical units. The corresponding multi-faceted chain of healthcare events is likely to be severely disturbed or even temporarily broken under the force majeure conditions such as global pandemics. Consequently, the chronic liver disease is highly representative for the management of any severe chronic disorder under lasting pandemics with unprecedented numbers of acutely diseased persons who, together with the chronically sick patient cohorts, have to be treated using the given capacity of healthcare systems with their limited resources.


    In this study, researchers explored the potential negative impact of the SARS CoV-2 outbreak on the quality of the advanced chronic liver disease (ACLD) management by considering two well-classified parameters: (1) the continuity of the patient registrations and (2) the level of mortality rates, comparing pre-COVID-19 statistics with these under the current pandemic in Slovak Republic.

  • Featured article: Prostate cancer management

    Societies around the world are facing the paradoxal epidemic development of prostate cancer (PCa) as a non-communicable disease. PCa is the most frequently diagnosed cancer for men in several countries such as the USA. Permanently improving diagnostics and treatments in the PCa management causes an impressive divergence between, on one hand, permanently increasing numbers of diagnosed PCa cases and, on the other hand, stable or even slightly decreasing mortality rates. 


    The article (this opens in a new tab) summarises knowledge accumulated in regard to the PCa-relevant non-modifiable and modifiable risk factors, highlights current deficits in PCa managements and presents innovative solutions in the context of predictive, preventive and personalised (3P) medicine.

  • 2019 Journal Metrics

    SCImago Journal Rank (SJR) measures weighted citations received by the journal. In 2019, the SJR for EPMA Journal is 1.263 (this opens in a new tab), placing it in the 1st quartile of the 'Health Policy' category, with particularly high level of international collaboration amongst researchers.


    Scopus CiteSore measures average citations received per document published. The 2019 CiteSore for EPMA Journal is 7.700 (this opens in a new tab). This ranks the journal as 8th in the 'Health Policy' category, within the 96th percentile.


    Source-Normalized Impact per Paper (SNIP) measures actual citations received relative to citations expected for the journal’s subject field. The 2019 SNIP for EPMA Journal is 1.469 (this opens in a new tab).

  • COVID-19 and impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

  • Meet our Editor-in-Chief, Professor Dr. Olga Golubnitschaja

    Prof. Dr. Golubnitschaja is the head of the world first Predictive, Preventive Personalised (3P) Medicine unit at the Department of Radiation Oncology, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Germany. OG is educated in journalism, biotechnology and medicine and has been awarded research fellowships in Austria, Russia, UK, Germany, Netherlands, and Switzerland (early and predictive diagnostics in paediatrics, neurosciences and cancer).

Navigation